- by Health CanadaDocument to announce multiple updates to the Prescription Drug List.
- by Health CanadaDocument to announce an amendment to the qualifier for melatonin on the Prescription Drug List.
- by Health CanadaGlucagon for injection is used for the emergency treatment of severe hypoglycemia (low blood sugar). Beginning in May 2023, we allowed Amphastar Pharmaceuticals Inc. to import US-authorized Glucagon for injection.
- by Health CanadaDocument to announce Health Canada’s intent to revise the qualifier for melatonin on the Prescription Drug List.
- by Health CanadaDocument to announce a consultation on the proposal to change the veterinary omeprazole listing on the Prescription Drug List (PDL).
- by Health CanadaDocument to announce multiple updates to the Prescription Drug List.
- by Health CanadaPhenytoin sodium capsules and phenytoin chewable tablets are used to control seizures. Supply constraints could impact the availability of these drugs in Canada until early May 2026.
- by Health CanadaThe Pharmaceutical and Life Sciences Sector Task Force is a joint federal initiative led by Health Canada and Innovation, Science and Economic Development Canada. The task force will support reliable and sustainable access to pharmaceutical products for people in Canada and identify made-in-Canada solutions that drive innovation, competitiveness and long-term growth in the life sciences sector.
- by Health CanadaDocuments to announce multiple updates to the Prescription Drug List.
- by Health CanadaDocument to announce a consultation on the proposal to remove zuranolone from the Prescription Drug List (PDL).
- by Health CanadaAn overview of drug and medical device shortages in Canada for the 2024 to 2025 fiscal year.
- by Health CanadaDocuments to announce that Health Canada has revised the qualifier of the “Nicotine or its salts” listing on the human use part of the Prescription Drug List (PDL).
- by Health CanadaHealth Canada has drafted a guidance document on decentralized clinical trials. The draft guidance outlines regulatory considerations and practical strategies for conducting clinical trials with decentralized elements in Canada.
- by Health CanadaHealth Canada is seeking feedback on the proposed Clinical Trials Regulations for drugs (pharmaceuticals, biologics and radiopharmaceuticals) and on multiple guidance documents related to the proposal.
- by Health CanadaDocuments to announce multiple updates to the Prescription Drug List.